Dihydromyricetin Ameliorates Cardiac Ischemia/Reperfusion Injury through Sirt3 Activation

Figure 2

DHM improved cardiac function after MI/R. (a, b) LVEF, LVFS was measured by echocardiography. (c, d) The maximal ± LV dp / dt was obtained by hemodynamic evaluation. Mean ± SEM (n=12), P<0.05 vs WT+sham group; ^#P<0.05 vs Sirt3^−/− + sham group; ^§P < 0.05 vs MI/R group; P<0.05 vs Sirt3^−/−+MI/R group; ^&P<0.05 vs MI/R +DHM group.

(a)

(b)

(c)

(d)